Microchips Biotech, Inc. is dedicated to improving the lives of patients by revolutionizing drug delivery. Our proprietary microchip-based implant can store and release precise doses of drugs over months and years. The implant, which is placed under the skin by a trained physician during a simple office procedure using local anesthesia, can be wirelessly activated or deactivated by a physician or patient, without requiring removal. In addition, physicians can wirelessly modify the frequency or dose of the drug to meet the individual needs of each patient.
Our proprietary microchip-based implant can store and release precise doses of drugs over months and years.
Our commercialization strategy is focused on using our implant to deliver established and currently-approved preventative and therapeutic agents that require frequent, critical or long-term dosing.
We are developing applications for the microchip-based implant in multiple therapeutic indications including osteoporosis, diabetes, multiple sclerosis and women’s contraception and partner with industry and foundations to meet patient needs across the globe.
Microchips was co-founded by renowned MIT researchers Robert Langer, PhD and Michael J. Cima, PhD, and is funded by leading healthcare and technology venture investors including Polaris Partners, Medtronic, InterSouth, Flybridge Capital and InterWest.